Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Cancer. 2008 Jul 15;113(2):293–301. doi: 10.1002/cncr.23552

TABLE 3.

Toxicities*

Adverse events Grade 1 Grade 2 Grade 3 Grade 4
Allergic rhinitis 8 9
Hemoglobin decrease 43 28 5
Leukopenia 8 21 1
Thrombocytopenia 33 39 20 3
Edema 41 47 2
Hypotension 2 34 99 5
Myocardial ischemia 2 3 1
Myocarditis 1
Arrhythmia (ie, SVT, etc) 56 10 11 3
Chills 1 53 34
Fatigue 20 63 34
Rash 26 32 16 2
Ascites 3 7
Diarrhea 38 26 58
Mucositis 21 13 3
Nausea 21 59 56 3
Vomiting 1
Melena/GI bleed 1
Hematuria 3
Hemorrhage 5 1 1 2
Infection 2 5 9 3
Catheter infection 4 4
Increased AST 50 19 5
Hyperbilirubinemia 62 78 15
Hypocalcemia 1
Increased creatinine 62 47 5
Confusions 11 15 21 14
Hallucinations 1
Depressed level of consciousness 8 8 13 8
Respiratory disorder 14 48 17 8
Pleural effusion 4 13 3
Low urine output due to CLS 38 11
Renal failure 1

SVT indicates supraventricular tachycardia; GI, gastrointestinal; AST, aspartate aminotransferase; CLS, capillary leak syndrome.

*

Determined according to the National Cancer Institute Common Toxicity Criteria grading system.